Bayer AG

Industry / private company


Location: Leverkusen, Germany (DE) DE

ISNI: 0000000403744101

ROR: https://ror.org/04hmn8g73

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

T cell-mediated elimination of cancer cells by blocking CEACAM6–CEACAM1 interaction (2022) Pinkert J, Boehm HH, Trautwein M, Doecke WD, Wessel F, Ge Y, Gutierrez EM, et al. Journal article Author Correction: Rare genetic variants affecting urine metabolite levels link population variation to inborn errors of metabolism (Nature Communications, (2021), 12, 1, (964), 10.1038/s41467-020-20877-8) (2021) Cheng Y, Schlosser P, Hertel J, Sekula P, Spiekerkoetter U, Mielke J, Freitag DF, et al. Journal article, Erratum Rare genetic variants affecting urine metabolite levels link population variation to inborn errors of metabolism (2021) Cheng Y, Schlosser P, Hertel J, Sekula P, Oefner PJ, Spiekerkoetter U, Mielke J, et al. Journal article Sirolimus in renal transplant recipients with malignancies in Germany (2021) Naik MG, Arns W, Budde K, Diekmann F, Eitner F, Gwinner W, Heyne N, et al. Journal article Self-Reported Medication Use and Urinary Drug Metabolites in the German Chronic Kidney Disease (GCKD) Study (2021) Kotsis F, Schultheiss UT, Wuttke M, Schlosser P, Mielke J, Becker MS, Oefner PJ, et al. Journal article EFFECTS OF FINERENONE ON CARDIORENAL OUTCOMES IN BLOOD PRESSURE SUBGROUPS IN PATIENTS WITH CKD AND T2D (2021) Ruilope L, Agarwal R, Anker SD, Filippatos G, Pitt B, Rossing P, Sarafidis P, et al. Conference contribution SELF-REPORTED MEDICATION USE AND URINARY DRUG METABOLITES IN THE GERMAN CHRONIC KIDNEY DISEASE (GCKD) STUDY: A PHARMACOMETABOLOMIC APPROACH (2021) Kotsis FK, Schultheiss UT, Wuttke M, Schlosser P, Oefner P, Mohney RP, Eckardt KU, et al. Conference contribution Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats (2020) Habermeyer J, Boyken J, Harrer J, Canneva F, Ratz V, Moceri S, Admard J, et al. Journal article Modeling and Simulation of Process Technology for Nanoparticulate Drug Formulations-A Particle Technology Perspective. (2020) Uhlemann J, Diedam H, Hoheisel W, Schikarski T, Peukert W Journal article, Review article Walking-related digital mobility outcomes as clinical trial endpoint measures: protocol for a scoping review (2020) Polhemus AM, Bergquist R, Bosch de Basea M, Brittain G, Buttery SC, Chynkiamis N, Dalla Costa G, et al. Journal article
1 2 3